South Korea

Dongkook Pharmaceutical Co.,Ltd.

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English Format: PDF Download Most recent financial data: 2016 Buy full report

What’s included?

This report extracts all available information about this company from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

7, Teheran-ro 108-gil Gangnam-gu Seoul
Seoul; Seoul; Map
Postal Code: 135502

Tel: 02-2191-
Fax: 02-566-

Company Description
Dongkook Pharmaceutical Co.,Ltd. is engaged in manufacturing pharmaceutical products. The company offer OTC (over the counter) drugs including Alprostadil injection, Teicoplanin injection, Propofol injection, Tritorelin depot injection, Iopamidol injection, Octreotide Lar injection, Gadopentate Dimeglumin injection, Leuprorelin Acetate injection, Sodium Hyaluronate injection and Streptokinase injection. Dongkook Pharmaceutical Co.,Ltd. alsos provides medicines for gingival disease, herbal-compound wound care ointment, medicine for menopause, anticancer products, as well as medical devices such as Bellast injection, Surgiquest, parasurgical and other medical components. The company is based in Seoul, South Korea. Dongkook Pharmaceutical Co.,Ltd. was incorporated in 1968.
NAICS Industry Classification
Basic Information
Key Executives
Ownership Details
Key Financial Highlights
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score

What this report allows you to do

EMIS company reports provide the data you need to make accurate assessments about businesses you are interested in.

Identify sales opportunities

  • Does the company match your target demographic?
  • Who are the key executives?

Conduct risk assessment

  • Is the company creditworthy?
  • Is it financially stable?

Carry out strategic research

  • Is the company a potential business partner/investment opportunity?
  • What is its financial performance?

You’re in good company

EMIS company reports are used extensively by the world’s biggest companies, financial institutions, professional service companies and universities to assess businesses in emerging markets.


company profiles

We have information on both public and private companies across 125 countries.



EMIS is the go-to information source on emerging market companies for the world’s most prestigious businesses.

Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

Contact us to learn more about our business solutions.
Sign up to our newsletter

Make sure you’re not the last to know by getting the latest insights on emerging markets straight to your inbox.